Insights From the PLCO Trial About Prostate Cancer Screening

被引：2
|
作者：
Gulati, Roman [1 ]
Albertsen, Peter C. [2 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave North,M2-B230,POB 19024, Seattle, WA 98109 USA
[2] Univ Connecticut, Ctr Hlth, Dept Surg, Div Urol, Farmington, CT USA
来源：
CANCER | 2017年 / 123卷 / 04期
关键词：
RANDOMIZED PROSTATE; MORTALITY; ERSPC;
D O I：
10.1002/cncr.30472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：546 / 548
页数：3
相关论文
共 50 条
  • [1] LETHAL PROSTATE CANCER IN THE PLCO CANCER SCREENING TRIAL
    Shoag, Jonathan
    Mittal, Sameer
    Halpem, Joshua
    Scherr, Douglas
    Hu, Jim
    Barbieri, Christopher
    JOURNAL OF UROLOGY, 2016, 195 (04): : E390 - E390
  • [2] Lethal Prostate Cancer in the PLCO Cancer Screening Trial
    Shoag, Jonathan
    Mittal, Sameer
    Halpern, Joshua A.
    Scherr, Douglas
    Hu, Jim C.
    Barbieri, Christopher E.
    EUROPEAN UROLOGY, 2016, 70 (01) : 2 - 5
  • [3] Re: Lethal Prostate Cancer in the PLCO Cancer Screening Trial
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2016, 196 (06): : 1677 - 1677
  • [4] Prostate cancer screening in the prostate, lung, colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the initial screening round of a randomized trial
    Andriole, GL
    Levin, DL
    Crawford, ED
    Gelmann, ER
    Pinsky, PF
    Chia, D
    Kramer, BS
    Reding, D
    Church, TR
    Grubb, RL
    Izmirlian, G
    Ragard, LR
    Clapp, JD
    Prorok, PC
    Gohagan, JK
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06): : 433 - 438
  • [5] Serum metabolomic profiling of prostate cancer risk in the PLCO Cancer Screening Trial
    Mondul, Alison M.
    Koutros, Stella
    Weinstein, Stephanie J.
    Berndt, Sonja I.
    Albanes, Demetrius
    CANCER RESEARCH, 2016, 76
  • [6] Prostate cancer risk and initial treatment decisions in the PLCO cancer screening trial
    Grubb, Robert L.
    Miller, David C.
    Church, Timothy R.
    Hickey, Thomas
    Greenlee, Robert T.
    Lzmirlian, Grant
    Mabie, Jerome
    Riley, Thomas L.
    Ragard, Lawrence
    Prorok, Philip C.
    Berg, Christine D.
    Crawford, E. David
    Andriole, Gerald L.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 153 - 153
  • [7] The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial - Preface
    Gohagan, JK
    CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 249S - 250S
  • [8] Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Prorok, PC
    Andriole, GL
    Bresalier, RS
    Buys, SS
    Chia, D
    Crawford, ED
    Fogel, R
    Gelmann, EP
    Gilbert, F
    Hasson, MA
    Hayes, RB
    Johnson, CC
    Mandel, JS
    Oberman, A
    O'Brien, B
    Oken, MM
    Rafla, S
    Reding, D
    Rutt, W
    Weissfeld, JL
    Yokochi, L
    Gohagan, JK
    CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 273S - 309S
  • [9] Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Hocking, William G.
    Hu, Ping
    Oken, Martin M.
    Winslow, Stephen D.
    Kvale, Paul A.
    Prorok, Philip C.
    Ragard, Lawrence R.
    Commins, John
    Lynch, David A.
    Andriole, Gerald L.
    Buys, Saundra S.
    Fouad, Mona N.
    Fuhrman, Carl R.
    Isaacs, Claudine
    Yokochi, Lance A.
    Riley, Thomas L.
    Pinsky, Paul F.
    Gohagan, John K.
    Berg, Christine D.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (10): : 722 - 731
  • [10] Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Pinsky, Paul F.
    Black, Amanda
    Parnes, Howard L.
    Grubb, Robert
    Crawford, E. David
    Miller, Anthony
    Reding, Douglas
    Andriole, Gerald
    CANCER EPIDEMIOLOGY, 2012, 36 (06) : E401 - E406
12345